Health Condition 1: I679- Cerebrovascular disease, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
CREST Neuroscience, Artemis Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 12 years or older. 2. The presence of an adequate radial artery diameter, defined as greater than equal to 1.7 mm, as confirmed through pre-procedural ultrasound evaluation. 3. Patients who have undergone procedure by RIST series of catheter. 4. Favorable aortic arch anatomy, assessed via computed tomography angiography (CTA) or digital subtraction angiography (DSA), deemed suitable for radial access. 5. Willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Presence of severe peripheral vascular disease or anatomical abnormalities of the radial artery e.g., radial artery loop that may hinder safe catheter navigation. 2. History of previous ipsilateral radial artery occlusion. 3. Contraindications to radial access, such as significant arterial calcification or vasospasm identified on ultrasound imaging
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is the effectiveness of catheterization using the RIST radial access system. Catheterization will be considered effective if the operator is able to navigate the Rist catheter to the desired target vessel via TRA without crossover to an alternate access siteTimepoint: Baseline Procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Procedural success rate: Defined as the ability to complete the intracranial portion of the procedure without switching to a different access site or guide catheter. 2. Assessed using access site and procedure-related complications. Access site complications: These will include radial artery spasm, hematoma, radial artery occlusion, dissection, or pseudoaneurysm. Each event will be documented, categorized by severity, and attributed to the device or technique where applicable. All events will be graded using the Common Terminology Criteria for Adverse Events (CTCAE).Timepoint: 7 days post procedure | — |
Countries
India
Contacts
Public ContactVikas Salgotra
Artemis Hospitals
Outcome results
None listed